Skip to main content

Pancreatic and Stomach Malignancies

  • Chapter
  • First Online:
  • 1615 Accesses

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

This is a preview of subscription content, log in via an institution.

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

    Article  PubMed  Google Scholar 

  2. Howlader NNA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2013. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/, based on November 2015 SEER data submission, posted to the SEER web site

  3. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27:1806–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903.

    Article  CAS  PubMed  Google Scholar 

  5. Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011;18:1319–26.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, Niedergethmann M, Zulke C, Fahlke J, Arning MB, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473–81.

    Article  CAS  PubMed  Google Scholar 

  7. Smeenk HG, van Eijck CH, Hop WC, Erdmann J, Tran KC, Debois M, van Cutsem E, van Dekken H, Klinkenbijl JH, Jeekel J. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg. 2007;246:734–40.

    Article  PubMed  Google Scholar 

  8. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.

    Article  CAS  PubMed  Google Scholar 

  9. Hsu CC, Herman JM, Corsini MM, Winter JM, Callister MD, Haddock MG, Cameron JL, Pawlik TM, Schulick RD, Wolfgang CL, et al. Adjuvant Chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study. Ann Surg Oncol. 2010;17:981–90.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kooby DA, Gillespie TW, Liu Y, Byrd-Sellers J, Landry J, Bian J, Lipscomb J. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Ann Surg Oncol. 2013;20:3634–42.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, et al. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer. 2013;119:2692–700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Loehrer PJ Sr, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB 3rd. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol. 2011;29:4105–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, et al. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012;84:1166–71.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouche O, Shannon J, Andre T, et al. Effect of Chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without Erlotinib: the LAP07 randomized clinical trial. JAMA. 2016;315:1844–53.

    Article  CAS  PubMed  Google Scholar 

  15. Ceha HM, van Tienhoven G, Gouma DJ, Veenhof CH, Schneider CJ, Rauws EA, Phoa SS, Gonzalez Gonzalez D. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer. 2000;89:2222–9.

    Article  CAS  PubMed  Google Scholar 

  16. Bittner MI, Grosu AL, Brunner TB. Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer - a systematic review. Radiother Oncol. 2015;114:117–21.

    Article  PubMed  Google Scholar 

  17. Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer. 2009;115:665–72.

    Article  PubMed  Google Scholar 

  18. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, Lacaine F, Paquet JC, Hay JM. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg. 1989;209:162–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Squires MH 3rd, Kooby DA, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Votanopoulos KI, Fields RC, Ejaz A, Acher AW, et al. Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. gastric cancer collaborative. Ann Surg Oncol. 2015;22:1243–51.

    Article  PubMed  Google Scholar 

  20. Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30:2327–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, Sohn I, Jung SH, Choi MG, Lee JH, et al. Phase III trial to compare adjuvant chemotherapy with Capecitabine and Cisplatin versus concurrent Chemoradiotherapy in gastric cancer: final report of the adjuvant Chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33:3130–6.

    Article  CAS  PubMed  Google Scholar 

  22. Ringash J, Perkins G, Brierley J, Lockwood G, Islam M, Catton P, Cummings B, Kim J, Wong R, Dawson L. IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys. 2005;63:732–8.

    Article  PubMed  Google Scholar 

  23. Megibow AJ, Babb JS, Hecht EM, Cho JJ, Houston C, Boruch MM, Williams AB. Evaluation of bowel distention and bowel wall appearance by using neutral oral contrast agent for multi-detector row CT. Radiology. 2006;238:87–95.

    Article  PubMed  Google Scholar 

  24. Suramo I, Paivansalo M, Myllyla V. Cranio-caudal movements of the liver, pancreas and kidneys in respiration. Acta Radiol Diagn (Stockh). 1984;25:129–31.

    Article  CAS  Google Scholar 

  25. Bryan PJ, Custar S, Haaga JR, Balsara V. Respiratory movement of the pancreas: an ultrasonic study. J Ultrasound Med. 1984;3:317–20.

    Article  CAS  PubMed  Google Scholar 

  26. Kissick MW, Mackie TR. Task group 76 report on 'The management of respiratory motion in radiation oncology' [med. Phys. 33, 3874-3900 (2006)]. Med Phys. 2009;36:5721–2.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kubo HD, Hill BC. Respiration gated radiotherapy treatment: a technical study. Phys Med Biol. 1996;41:83–91.

    Article  CAS  PubMed  Google Scholar 

  28. Minohara S, Kanai T, Endo M, Noda K, Kanazawa M. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1097–103.

    Article  CAS  PubMed  Google Scholar 

  29. Ford EC, Mageras GS, Yorke E, Rosenzweig KE, Wagman R, Ling CC. Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol Phys. 2002;52:522–31.

    Article  CAS  PubMed  Google Scholar 

  30. Ozhasoglu C, Murphy MJ. Issues in respiratory motion compensation during external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:1389–99.

    Article  PubMed  Google Scholar 

  31. Veiga C, Janssens G, Teng CL, Baudier T, Hotoiu L, McClelland JR, Royle G, Lin L, Yin L, Metz J, et al. First clinical investigation of cone beam computed tomography and deformable registration for adaptive proton therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2016;95:549–59.

    Article  PubMed  Google Scholar 

  32. Wong JW, Sharpe MB, Jaffray DA, Kini VR, Robertson JM, Stromberg JS, Martinez AA. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44:911–9.

    Article  CAS  PubMed  Google Scholar 

  33. Dawson LA, Brock KK, Kazanjian S, Fitch D, McGinn CJ, Lawrence TS, Ten Haken RK, Balter J. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys. 2001;51:1410–21.

    Article  CAS  PubMed  Google Scholar 

  34. Grassberger C, Dowdell S, Lomax A, Sharp G, Shackleford J, Choi N, Willers H, Paganetti H. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:380–6.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS, Ben-Josef E. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007;68:801–8.

    Article  CAS  PubMed  Google Scholar 

  36. Goodman KA, Regine WF, Dawson LA, Ben-Josef E, Haustermans K, Bosch WR, Turian J, Abrams RA. Radiation therapy oncology group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012;83:901–8.

    Article  PubMed  Google Scholar 

  37. Wo JY, Yoon SS, Guimaraes AR, Wolfgang J, Mamon HJ, Hong TS. Gastric lymph node contouring atlas: a tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer. Pract Radiat Oncol. 2013;3:e11–9.

    Article  PubMed  Google Scholar 

  38. Lin LSS, Kang M, et al. Evaluation of motion mitigation using abdominal compression in the clinical implementation of pencil beam scanning proton therapy of liver tumors. Med Phys. 2017;44(2):703–12.

    Article  CAS  PubMed  Google Scholar 

  39. Moyers MF, Miller DW, Bush DA, Slater JD. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys. 2001;49:1429–38.

    Article  CAS  PubMed  Google Scholar 

  40. Thompson RF, Mayekar SU, Zhai H, Both S, Apisarnthanarax S, Metz JM, Plastaras JP, Ben-Josef E. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys. 2014;41:081711.

    Article  PubMed  Google Scholar 

  41. Boimel P, Berman Abigail, Li, Jonathan, Apisarnthanarax, Smith, Both, Stefan, Lelionis, Kristi, Larson, Gary, Lukens, J. Nicholas, Ben-Josef, Edgar, Metz, James, Plastaras, John: Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma Poster at the American Society for Therapeutic Radiology and Oncology Annual Meeting San Antonio, Tx 2015.

    Google Scholar 

  42. Lin L: Implementation of Pencil Beam Scanning (PBS) Proton Therapy Treatment for Liver Patient. AAPM 58th Annual Meeting, Washington DC 2016.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edgar Ben-Josef .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Boimel, P.J., Scholey, J., Lin, L., Ben-Josef, E. (2018). Pancreatic and Stomach Malignancies. In: Lee, N., et al. Target Volume Delineation and Treatment Planning for Particle Therapy. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-42478-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42478-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42477-4

  • Online ISBN: 978-3-319-42478-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics